The present disclosure pertains to embodiments of multi-lumen cannulae that can be used to facilitate heart repair and/or other related procedures.
Surgically placed cannulae are frequently used in surgical procedures to draw or push blood into patient vessels. In some cases, multiple cannulae must be used during procedures. Current cannulae known in the art are typically made from a single lumen tube with multiple holes at the distal section. Such cannulae, however, cannot perform multiple functions and thus multiple cannulae are required to achieve such functions. As can be appreciated, using multiple cannulae adds complexity to the procedure, which can reduce efficiency and cause lengthy procedures and thereby cause potential patient complications and/or result in lengthy recovery times. Accordingly, a need exists in the art for a single cannula that is capable of performing multiple different functions during a procedure.
The present disclosure concerns embodiments of multi-lumen cannulae that can be used to facilitate multiple different procedures during an operation, such as a heart operation, within a patient's vasculature. The disclosed multi-lumen cannulae comprise an elongated body having a distal end portion for placement in a biological lumen of a patient and a proximal end portion for placement outside the patient. The multi-lumen cannulae also may have a first balloon and a second balloon connected to an exterior surface of the elongated body in the distal end portion. The first balloon and the second balloon can be configured to fluidly isolate, between the first and second balloons, a portion of the biological lumen of the patient when inflated. The multi-lumen cannulae also comprise a central lumen extending through the elongated body from the distal end portion to the proximal end portion, distal fluid ports and proximal fluid ports in the distal end portion of the elongated body that are fluidly coupled to the central lumen for conducting fluid between the biological lumen of the patient and the central lumen. The multi-lumen cannulae can also comprise at least one balloon sidewall lumen arranged parallel to the central lumen and located within an outer perimeter of the elongated body, and at least one balloon port. The at least one inflation and deflation port can fluidly couple the balloon sidewall lumen to the first balloon, the second balloon, or both, for inflation and deflation of the balloons. The multi-lumen cannulae also can comprise at least one conduction sidewall lumen and at least one intermediate fluid port located in an intermediate region of the distal end portion of the elongated body.
An exemplary embodiment of a multi-lumen cannula can comprise a first balloon sidewall lumen that is coupled to a first inflation and deflation port and a second balloon sidewall lumen that is coupled to a second inflation and deflation port. The multi-lumen cannula also can comprise two conduction sidewall lumens that are fluidly coupled to intermediate fluid ports. In some embodiments, the multi-lumen cannula also can comprise at least one conduction sidewall lumen that is fluidly coupled to at least one distal fluid port, a proximal fluid port, or a combination thereof. Distal fluid ports can be located in the distal region of the distal end portion of the elongated body and proximal fluid ports can be located in the proximal region of the distal end portion of the elongated body.
An exemplary method of using a multi-lumen cannula such as those disclosed herein comprises introducing a multi-lumen cannula into the vena cava of a patient and inflating a first balloon of the cannula within the inferior vena cava and a second balloon of the cannula within the superior vena cava to fluidly isolate the right atrium of the patient from the inferior vena cava or superior vena cava. The method can further comprise draining blood from the patent's inferior vena cava and superior vena cava through at least one distal fluid port in the cannula located distal to the first and second balloons and at least one proximal fluid port in the cannula located proximal to the first and second balloons, and conducting a fluid to or from the right atrium through at least one intermediate fluid port in the cannula located between the first balloon and the second balloon.
An exemplary embodiment of the method can involve introducing the multi-lumen cannula into the patient's vena cava from an inferior access point such that the first balloon is positioned proximal to the second balloon, wherein the inferior access point is in the femoral vein. In another embodiment, the multi-lumen cannula can be introduced into the patient's vena cava from a superior access point such that the first balloon is positioned proximal to the second balloon, wherein the superior access point is in internal jugular vein. The method also may comprise using the distal fluid ports, proximal fluid ports, and intermediate fluid ports to drain blood to a common blood reservoir. In some embodiments, the intermediate ports can drain blood to a first destination and the proximal fluid ports and the distal fluid ports can drain blood to a second destination segregated from the first destination. In exemplary embodiments, the intermediate ports can drain blood to a cell saver for hemoconcentration and the proximal fluid ports and distal fluid ports can drain blood to a cardiotomy reservoir for recirculation.
The foregoing and other objects, features, and advantages of the disclosed technology will become more apparent from the following detailed description, which proceeds with reference to the accompanying figures.
The present disclosure concerns embodiments of multi-lumen cannulae that comprise multiple lumens capable of facilitating a variety of different procedures that may be performed during a heart valve operation and/or other medical procedure. The disclosed multi-lumen cannulae can be used to conduct fluid into or out of vessels during minimally invasive surgery or open heart surgeries. Because the multi-lumen cannulae disclosed herein can comprise multiple lumens within a single cannula body, additional separate cannulae may not be necessary. The disclosed multi-lumen cannulae can therefore provide more efficient means for providing alternative blood flow routes during surgery as multiple different cannulae may not need to be introduced and/or removed from the patient, which can reduce physical stress to the patient and can increase the speed of application of the cannulae.
The disclosed multi-lumen cannulae can also be used to control and/or localize cardioplegia solution delivery to particular sections of the heart, such as the right atrium, thereby preventing mixing in undesired regions of the patients' circulatory system. For example, in some embodiments, blood from the inferior vena cava (referred to herein as “IVC”) and the superior vena cava (referred to herein as “SVC”) can be isolated from the cardioplegia solution as it is delivered to the patient's heart. The disclosed multi-lumen cannulae also can be kink-resistant, and may not require braided tubing or structure-reinforcing materials for operation.
The examples provided below describe various features of the disclosed multi-lumen cannulae as well as configurations of various portions of the cannulae that can facilitate their use in medical procedures, such as heart valve repairs (e.g., tricuspid valve procedures, mitral valve repairs, or aortic valve repairs), coronary artery bypass grafts, or extracorporeal membrane oxygenation (ECMO) (e.g., veno-arterial ECMO or veno-venous ECMO). Embodiments of the cannulae can be used for blood drainage, blood delivery, and/or cardioplegia solution delivery during certain procedures. These particular applications are intended to be exemplary; the cannulae can also be used to facilitate other types of heart procedures, non-heart related procedures, and/or patient support.
Blood can be conducted from a patient's vein to an external reservoir through the multi-lumen cannula. The blood can be conducted using passive or active conduction. Passive conduction is understood herein to mean conducting blood through at least one lumen of a multi-lumen cannula without applying an external vacuum to facilitate flow. Active conduction is understood herein to mean conducting blood through at least one lumen of a multi-lumen cannula by applying an external vacuum.
As shown in
The distal region 104 can also comprise at least one distal fluid port 114 (which can also be referred to as a side port) (
The distal fluid ports 114 can be formed by punching and/or drilling holes in the exterior perimeter of the distal region 104 through to the central lumen 144 (
As illustrated in
The distal fluid ports 114, proximal fluid ports 115, or combinations thereof can be configured to access blood flowing within the patient's SVC and/or IVC and conduct the blood to an external reservoir.
The distal fluid ports 114 and proximal fluid ports 115 can be configured to have any shape and any arrangement within the distal end portion 102 that is suitable for conducting blood from a biological lumen to a central lumen and/or one or more sidewall lumens. In some embodiments, the size, shape, and arrangement of the distal fluid ports and the proximal fluid ports can be selected to provide (or improve) a maximum flow requirement for a particular procedure.
Multi-lumen cannulae embodiments disclosed herein also can comprise one or more intermediate fluid ports positioned within an intermediate region of the distal end portion of the cannula. Such intermediate fluid ports can be used for a variety of purposes. In some embodiments, the intermediate fluid ports can be used to deliver a cardioplegia solution to a patient during an operation. The intermediate fluid ports also can be utilized to conduct fluids other than a cardioplegia solution (such as oxygenated blood, deoxygenated blood, etc.) to and from the patient.
An exemplary embodiment of a multi-lumen cannula comprising intermediate fluid ports is illustrated in
As with the distal and proximal fluid ports 114, 115, any size, shape, number, and/or arrangement of the intermediate fluid ports 124 can be included. The size, shape, number, and/or arrangement of the intermediate fluid ports can be selected independent of the size, shape, number, and/or arrangement of the distal and/or proximal fluid ports.
One or more of the intermediate fluid ports 124 can be independently fluidly coupled to one of the two conduction sidewall lumens 150 illustrated in
The multi-lumen cannulae embodiments disclosed herein can also comprise one or more balloons capable of being inflated and deflated. In some embodiments, the balloons can be inflated to facilitate a particular medical procedure. For example, the balloons can be inflated to isolate the right atrium of the heart from the IVC and the SVC. As illustrated in
In some embodiments, a single sidewall lumen 148 can be included to conduct an inflation fluid to and from both balloon ports 120 and 122. Balloons 116 and 118 can therefore be inflated and deflated at substantially the same time by conducting the inflation fluid through the single balloon sidewall lumen 148 to both balloon ports 120 and 122. In other embodiments, each balloon can be coupled to an independent lumen such that each balloon can be inflated or deflated at different times.
Another embodiment of the disclosed multi-lumen cannulae is illustrated in
As illustrated in
Multi-lumen cannula 300, as illustrated in
In some embodiments, the balloons can be inflated (and ultimately deflated) sequentially to ensure that the balloon positioned within the IVC is positioned in a suitable location before the balloon positioned within the SVC is inflated. For example, the balloon that is to be positioned within the IVC can be positioned so that it blocks the right atrium from blood flowing from the IVC to the right atrium. In some embodiments, the balloon is positioned within the IVC so that the outer periphery of the balloon sits approximately 4 cm from the inferior end of the right atrium to avoid covering the patient's hepatic veins and thereby prevent disrupted blood flow to the hepatic system. Alternatively, the SVC balloon can be inflated before the IVC balloon.
In other procedures, the balloons 316, 318 can be inflated (and ultimately deflated) simultaneously, or substantially simultaneously. Simultaneous inflation can be accomplished by administering an inflation fluid into the two independent sidewall lumens 322, 330 at the same time, such as from a common source.
The cannula can also comprise a proximal end portion connected to, or continuing from the distal end portion. The proximal end portion of the multi-lumen cannula can comprise a handle portion suitable for manipulating/controlling flow through the multi-lumen cannula. In some embodiments, the handle can be used to deliver a fluid to the patient. For example, the cardioplegia solution and/or the inflation fluid discussed above can be delivered to the different intermediate fluid ports and/or balloon ports disclosed herein via the corresponding conduction sidewall lumens and/or balloon sidewall lumens that extend from the proximal end portion of the elongated body to the distal end portion of the elongated body. In some embodiments, the handle can be used to facilitate oxygenated blood flow into the cannula from an external heart/lung machine or other source during ECMO.
Exemplary embodiments of a handle that can be included with a multi-lumen cannula are illustrated in
One or more adaptor ridges 134 and tapered tip 136 can be included in the proximal region 138 of the proximal end portion 126, as illustrated in
Another embodiment of a multi-lumen cannula comprising a handle is illustrated in
The sidewall lumens of the multi-lumen cannula can terminate at different axial locations along the cannula, independently of the central lumen. For example, a sidewall lumen that is fluidly coupled to an intermediate fluid port within an intermediate region of the distal end portion can terminate within the intermediate region so that it does not extend into a distal region. In some embodiments, the distal region of the distal end portion can comprise a single lumen tube. Sidewall lumens fluidly coupled to balloon ports also can also be configured to terminate prior to the distal region of the distal end portion of the cannula. Thus, the number of lumens can decrease moving axially toward the distal end of the cannula.
The multi-lumen cannulae disclosed herein can comprise a variety of suitable materials, including polymers (e.g., polyurethane, nylon, polytetrafluoroethylene, polyvinylchloride, and the like), metals (e.g., stainless steel or Ninitol), alloys, composites, or combinations thereof. In certain embodiments, the cannula can be extruded or wire wound. Extruded embodiments can be sufficiently strong such that exterior support (such as a metal coil) around the cannula may not be necessary. In some embodiments, however, the cannula can be reinforced with a material that promotes crush resistance, such as a coil or sheath.
The diameter of the elongated body of a multi-lumen cannula can vary thereby affording different cannula embodiments that can be used in differently sized patients and in different biological lumens present in a patient's vasculature, such as the vena cava (including the SVC and the IVC), the internal jugular vein, the femoral vein, and the like. For example, the elongated body of a multi-lumen cannula can have an outer diameter of about 0.2 inches to about 0.4 inches, with some embodiments having an outer diameter of about 0.27 inches to about 0.33 inches. The diameter of the cannula can be larger in the regions of the elongated body that include a handle or a balloon.
As the multi-lumen cannulae disclosed herein can be introduced into the patient through the femoral vein or the internal jugular vein or other vessels, the length of a particular cannula can be selected to accommodate the particular biological lumen into which it is to be placed.
In some embodiments, the elongated body can have a length of about 55 cm to about 65 cm from the distal tip to the end of the proximal region of the distal end portion. Such embodiments can be used for a femoral approach. In other embodiments, the elongated body can have a length of about 20 cm to about 45 cm from the distal tip to the end of the proximal region of the distal end portion. Such embodiments can be used for an internal jugular approach.
Each of the distal region and the proximal region of the distal end portion of the elongated body can have a length ranging from about 3 cm to about 20 cm. Referring to
In embodiments wherein a femoral approach is used, the distal region of the distal end portion of the elongated body can have a length 1000 ranging from about 3 cm to about 7 cm and the proximal region of the distal end portion can have a length 1002 ranging from about 5 cm to about 20 cm. When a multi-lumen cannula is inserted through an internal jugular vein of the patient, the distal region of the distal end portion can have a length woo of about 5 cm to about 20 cm, and the proximal region of the distal end portion can have a length 1002 of about 3 cm to about 10 cm.
The balloons used with the disclosed multi-lumen cannulae can be made of any suitable material, such as, but not limited to, latex, silicone, polyethylene, polyurethane, or combinations thereof. The outer surface of the balloons can be textured or smooth. The balloons can be bonded to the exterior surface of the cannulae using a suitable adhesive typically used in the art. The balloons can be separated by a distance 1004 of about 5 cm to about 15 cm, as measured from the proximal end of the balloon positioned closest to the distal end to the distal end of the balloon positioned closest to the proximal end. In some embodiments, the distance 1004 is about 14 cm. The balloons can have a length 1006 of up to about 2 cm, with some embodiments comprising balloons having a length 1006 of about 1 cm.
Sidewall lumens can be formed within a multi-lumen cannula by using a suitable extrusion method, for example. In particular disclosed embodiments, the cross-sectional area of the sidewall lumens can be maximized to facilitate actively conducting blood and/or a fluid to and from the patient. The cross-sectional area of the sidewall lumens also can be configured to minimize the amount of cannula material present within the body of the multi-lumen cannula so as to maximize the area of each sidewall lumen and/or the central lumen.
Additionally, the distance or area between the sidewall lumens and the outer perimeter of the cannula and/or the outer perimeter of the central lumen can be minimized to facilitate use. In some embodiments, a suitable distance or area between the sidewall lumens and the outer perimeter of the cannula and/or the outer perimeter of the central lumen is maintained to prevent, or substantially prevent kinking of the cannula.
In different embodiments, any suitable spacing/positioning can be used. The sidewall lumens also may have any shape and/or size suitable for performing a desired function, such as cardioplegia delivery, active or passive conduction, inflation and/or deflation. In some embodiments, the sidewall lumens can be oval-shaped and have a major diameter 1100, as illustrated in
The disclosed multi-lumen cannulae can be used in various different procedures. In some implementations, all or some of the lumens and ports can be used for common blood drainage from the vena cava and right atrium without inflating the balloons to isolate the right atrium.
Another exemplary implementation of the multi-lumen cannula 1300 is illustrated in
In other implementations, the disclosed multi-lumen cannulae can be used for cardioplegia delivery during a heart procedure. In such implementations, the two balloons are inflated to isolate the right atrium from the SVC and the IVC. The central lumen and/or one or more of the sidewall lumens is used to drain blood from the SVC and the IVC, such as to an external cardiotomy reservoir for recirculation, while intermediate fluid ports of the cannula are fluidly coupled to one or more sidewall lumens and selectively drain blood from the right atrium to an external cell saver for hemoconcentration. This selective drainage can occur when a cardioplegia solution is being delivered to allow the cardioplegia solution to be selectively removed from circulation. This use of the intermediate ports and sidewall lumens can reduce the need for hemoconcentration at a later stage in the operation thereby reducing any negative impacts on the patient's blood chemistry. Single- or multiple-dose cardioplegia can be delivered with the disclosed multi-lumen cannulae.
The disclosed multi-lumen cannulae also can be used during a procedure that requires incision into the right portion of the heart, such as the right atrium (e.g., tricuspid valve repair). In such embodiments, the multi-lumen cannulae can be manipulated to facilitate the procedure by stopping flow through the sidewall lumens in communication with the ports in the intermediate region between the two balloons such that no fluid is conducted into or out of the right atrium. Blood can then be drained from the SVC and the IVC through the central lumen and/or sidewall lumens without effecting the right atrium. The surgeon may then optionally snare around the right atrium prior to performing the desired right-heart procedure.
In other implementations, the disclosed multi-lumen cannulae can be used in an ECMO procedure, such as veno-arterial ECMO. In some implementations, the central lumen and optionally one or more of the sidewall lumens can be used to facilitate blood drainage from the SVC and the IVC, while one or more of the sidewall lumens are used to re-infuse oxygenated blood into the right atrium from an external source, such as a heart/lung machine. The re-infused blood can be introduced into the right atrium through intermediate ports positioned between the two balloons of the cannula. In such embodiments, the balloons need not be inflated; however, the balloons of the multi-lumen cannulae can be inflated to avoid mixing oxygenated and deoxygenated blood, thereby improving the oxygen saturation of blood being delivered to the right atrium.
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatuses, and systems should not be construed as limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatuses, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing embodiments. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
Although the operations of some of the disclosed methods are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. As used herein, the terms “a”, “an”, and “at least one” encompass one or more of the specified element. That is, if two of a particular element are present, one of these elements is also present and thus “an” element is present. The terms “a plurality of” and “plural” mean two or more of the specified element.
As used herein, the term “and/or” used between the last two of a list of elements means any one or more of the listed elements. For example, the phrase “A, B, and/or C” means “A”, “B,”, “C”, “A and B”, “A and C”, “B and C”, or “A, B, and C.”
As used herein, the term “coupled” generally means physically, chemically, electrically, magnetically, or otherwise coupled or linked and does not exclude the presence of intermediate elements between the coupled items absent specific contrary language.
In view of the many possible embodiments to which the principles of the disclosed technology may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the disclosed technology and should not be taken as limiting the scope of the technology. Rather, the scope of the disclosed technology is at least as broad as the following claims. We therefore claim all that comes within the scope of these claims.
This application is a continuation of U.S. patent application Ser. No. 16/820,614, filed on Mar. 16, 2020, which is a continuation of U.S. patent application Ser. No. 15/501,801, filed on Feb. 3, 2017, which is a U.S. National Stage of International Application No. PCT/US2015/044003, filed Aug. 6, 2015, which claims the benefit of U.S. patent application Ser. No. 62/033,987, filed Aug. 6, 2014, the entire disclosures all of which are incorporated by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
528759 | Bernhardt | Nov 1894 | A |
3143742 | Cromie | Aug 1964 | A |
3164009 | Schaschl | Jan 1965 | A |
3320972 | High et al. | May 1967 | A |
3371352 | Siposs et al. | Mar 1968 | A |
3409013 | Berry | Nov 1968 | A |
3546710 | Shumakov et al. | Dec 1970 | A |
3574865 | Hamaker | Apr 1971 | A |
3628535 | Ostrowsky et al. | Dec 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3686740 | Shiley | Aug 1972 | A |
3755823 | Hancock | Sep 1973 | A |
3839741 | Haller | Oct 1974 | A |
4016867 | King et al. | Apr 1977 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4062911 | Pepping | Dec 1977 | A |
4078468 | Civitello | Mar 1978 | A |
4079468 | Liotta et al. | Mar 1978 | A |
4084268 | Ionescu et al. | Apr 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4172295 | Batten | Oct 1979 | A |
4185638 | Bruner | Jan 1980 | A |
4211241 | Kaster et al. | Jul 1980 | A |
4217665 | Bex et al. | Aug 1980 | A |
4218782 | Rygg | Aug 1980 | A |
4252131 | Hon et al. | Feb 1981 | A |
4259753 | Liotta et al. | Apr 1981 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4362167 | Nicolai et al. | Dec 1982 | A |
4364126 | Rosen et al. | Dec 1982 | A |
4372743 | Lane | Feb 1983 | A |
4388735 | Ionescu et al. | Jun 1983 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4451936 | Carpentier et al. | Jun 1984 | A |
4470157 | Love | Sep 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4501030 | Lane | Feb 1985 | A |
4506394 | Bedard | Mar 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4566465 | Arhan et al. | Jan 1986 | A |
4585453 | Martin et al. | Apr 1986 | A |
4602911 | Ahmadi et al. | Jul 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4626255 | Reichart et al. | Dec 1986 | A |
4629459 | Ionescu et al. | Dec 1986 | A |
4643194 | Fogarty | Feb 1987 | A |
4679556 | Lubock et al. | Jul 1987 | A |
4680031 | Alonso | Jul 1987 | A |
4685474 | Kurz et al. | Aug 1987 | A |
4687483 | Fisher et al. | Aug 1987 | A |
4702250 | Ovil et al. | Oct 1987 | A |
4705516 | Barone et al. | Nov 1987 | A |
4725274 | Lane et al. | Feb 1988 | A |
4731074 | Rousseau et al. | Mar 1988 | A |
4778461 | Pietsch et al. | Oct 1988 | A |
4790843 | Carpentier et al. | Dec 1988 | A |
4851000 | Gupta | Jul 1989 | A |
4865600 | Carpentier et al. | Sep 1989 | A |
4888009 | Lederman et al. | Dec 1989 | A |
4898155 | Ovil et al. | Feb 1990 | A |
4914097 | Oda et al. | Apr 1990 | A |
4940459 | Noce | Jul 1990 | A |
4960424 | Grooters | Oct 1990 | A |
4993428 | Arms | Feb 1991 | A |
5010892 | Colvin et al. | Apr 1991 | A |
5011481 | Myers et al. | Apr 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5042161 | Hodge | Aug 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5089015 | Ross | Feb 1992 | A |
5147391 | Lane | Sep 1992 | A |
5163955 | Love et al. | Nov 1992 | A |
5171248 | Ellis | Dec 1992 | A |
5197979 | Quintero et al. | Mar 1993 | A |
5236450 | Scott | Aug 1993 | A |
5258023 | Reger | Nov 1993 | A |
5290300 | Cosgrove et al. | Mar 1994 | A |
5312344 | Grinfeld et al. | May 1994 | A |
5316016 | Adams et al. | May 1994 | A |
5326370 | Love et al. | Jul 1994 | A |
5326371 | Love et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360014 | Sauter et al. | Nov 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5376112 | Duran | Dec 1994 | A |
5396887 | Imran | Mar 1995 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411522 | Trott | May 1995 | A |
5423887 | Love et al. | Jun 1995 | A |
5425741 | Lemp et al. | Jun 1995 | A |
5431676 | Dubrul et al. | Jul 1995 | A |
5449384 | Johnson | Sep 1995 | A |
5449385 | Religa et al. | Sep 1995 | A |
5460610 | Don Michael | Oct 1995 | A |
5469868 | Reger | Nov 1995 | A |
5471756 | Bolanos et al. | Dec 1995 | A |
5476510 | Eberhardt et al. | Dec 1995 | A |
5488789 | Religa et al. | Feb 1996 | A |
5489296 | Love et al. | Feb 1996 | A |
5489297 | Duran | Feb 1996 | A |
5489298 | Love et al. | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5500016 | Fisher | Mar 1996 | A |
5531785 | Love et al. | Jul 1996 | A |
5533515 | Coller et al. | Jul 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5562729 | Purdy et al. | Oct 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5573007 | Bobo, Sr. | Nov 1996 | A |
5578076 | Krueger et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5584878 | Love et al. | Dec 1996 | A |
5618307 | Donlon et al. | Apr 1997 | A |
5626607 | Malecki et al. | May 1997 | A |
5628789 | Vanney et al. | May 1997 | A |
5653749 | Love et al. | Aug 1997 | A |
5662705 | Love et al. | Sep 1997 | A |
5693090 | Unsworth et al. | Dec 1997 | A |
5695503 | Krueger et al. | Dec 1997 | A |
5713952 | Vanney et al. | Feb 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728064 | Burns et al. | Mar 1998 | A |
5728151 | Garrison et al. | Mar 1998 | A |
5735894 | Krueger et al. | Apr 1998 | A |
5752522 | Murphy | May 1998 | A |
5755782 | Love et al. | May 1998 | A |
5766240 | Johnson | Jun 1998 | A |
5776187 | Krueger et al. | Jul 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5800527 | Jansen et al. | Sep 1998 | A |
5814096 | Lam et al. | Sep 1998 | A |
5814097 | Sterman et al. | Sep 1998 | A |
5814098 | Hinnenkamp et al. | Sep 1998 | A |
5824064 | Taheri | Oct 1998 | A |
5824068 | Bugge | Oct 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5843177 | Vanney et al. | Dec 1998 | A |
5848969 | Panescu et al. | Dec 1998 | A |
5855563 | Kaplan et al. | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5865801 | Houser | Feb 1999 | A |
5885228 | Rosenman et al. | Mar 1999 | A |
5891160 | Williamson, IV et al. | Apr 1999 | A |
5895420 | Mirsch, II et al. | Apr 1999 | A |
5902308 | Murphy | May 1999 | A |
5908450 | Gross et al. | Jun 1999 | A |
5919147 | Jain | Jul 1999 | A |
5921934 | Teo | Jul 1999 | A |
5921935 | Hickey | Jul 1999 | A |
5924984 | Rao | Jul 1999 | A |
5928281 | Huynh et al. | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5972004 | Williamson, IV et al. | Oct 1999 | A |
5984959 | Robertson et al. | Nov 1999 | A |
5984973 | Girard et al. | Nov 1999 | A |
6001126 | Nguyen-Thien-Nhon | Dec 1999 | A |
6010511 | Murphy | Jan 2000 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6019739 | Rhee et al. | Feb 2000 | A |
6042554 | Rosenman et al. | Mar 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6045576 | Starr et al. | Apr 2000 | A |
6050973 | Duffy | Apr 2000 | A |
6059827 | Fenton, Jr. | May 2000 | A |
6066160 | Colvin et al. | May 2000 | A |
6074418 | Buchanan et al. | Jun 2000 | A |
6081737 | Shah | Jun 2000 | A |
6083179 | Oredsson | Jul 2000 | A |
6099475 | Seward et al. | Aug 2000 | A |
6099506 | Macoviak et al. | Aug 2000 | A |
6106550 | Magovern et al. | Aug 2000 | A |
6110200 | Hinnenkamp | Aug 2000 | A |
6117091 | Young et al. | Sep 2000 | A |
6126007 | Kari et al. | Oct 2000 | A |
6136017 | Craver et al. | Oct 2000 | A |
6166184 | Hendriks et al. | Dec 2000 | A |
6197014 | Samson et al. | Mar 2001 | B1 |
6210338 | Afremov et al. | Apr 2001 | B1 |
6214054 | Cunanan et al. | Apr 2001 | B1 |
6264611 | Ishikawa et al. | Jul 2001 | B1 |
6319281 | Patel | Nov 2001 | B1 |
6322526 | Rosenman et al. | Nov 2001 | B1 |
6350281 | Rhee | Feb 2002 | B1 |
6350282 | Eberhardt | Feb 2002 | B1 |
6491624 | Lotfi | Dec 2002 | B1 |
6533770 | Lepulu et al. | Mar 2003 | B1 |
6582419 | Schoon et al. | Jun 2003 | B1 |
6598307 | Love et al. | Jul 2003 | B2 |
6626872 | Navia et al. | Sep 2003 | B1 |
6669674 | Macoviak et al. | Dec 2003 | B1 |
6726651 | Robinson | Apr 2004 | B1 |
6773457 | Ivancev et al. | Aug 2004 | B2 |
6802860 | Cosgrove et al. | Oct 2004 | B2 |
6846324 | Stobie | Jan 2005 | B2 |
6942694 | Liddicoat et al. | Sep 2005 | B2 |
7007396 | Rudko et al. | Mar 2006 | B2 |
7018404 | Holmberg et al. | Mar 2006 | B2 |
7037333 | Myers et al. | May 2006 | B2 |
7258698 | Lemmon | Aug 2007 | B2 |
7270142 | Acosta | Sep 2007 | B2 |
7351197 | Montpetit et al. | Apr 2008 | B2 |
7637943 | Lemmon | Dec 2009 | B2 |
7713216 | Dubey et al. | May 2010 | B2 |
7842084 | Bicer | Nov 2010 | B2 |
7998151 | St. Goar et al. | Aug 2011 | B2 |
8057396 | Forster et al. | Nov 2011 | B2 |
8308798 | Pintor et al. | Nov 2012 | B2 |
8323337 | Gurskis et al. | Dec 2012 | B2 |
8348998 | Pintor et al. | Jan 2013 | B2 |
8449625 | Campbell et al. | May 2013 | B2 |
8475521 | Suri et al. | Jul 2013 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010039435 | Roue et al. | Nov 2001 | A1 |
20010039436 | Frazier et al. | Nov 2001 | A1 |
20010041914 | Frazier et al. | Nov 2001 | A1 |
20010041915 | Roue et al. | Nov 2001 | A1 |
20010049492 | Frazier et al. | Dec 2001 | A1 |
20020020074 | Love et al. | Feb 2002 | A1 |
20020026238 | Lane et al. | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020055773 | Campbell et al. | May 2002 | A1 |
20020058995 | Stevens | May 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020138138 | Yang | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020188348 | DiMatteo et al. | Dec 2002 | A1 |
20020198594 | Schreck | Dec 2002 | A1 |
20030004452 | Lenker | Jan 2003 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030023300 | Bailey et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030036795 | Andersen et al. | Feb 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030055495 | Pease et al. | Mar 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030109924 | Cribier | Jun 2003 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030149478 | Figulla et al. | Aug 2003 | A1 |
20030167089 | Lane | Sep 2003 | A1 |
20030176830 | Scheule | Sep 2003 | A1 |
20030191416 | Rosenman et al. | Oct 2003 | A1 |
20030236568 | Hojeibane et al. | Dec 2003 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040034411 | Quijano et al. | Feb 2004 | A1 |
20040044406 | Woolfson et al. | Mar 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040122516 | Fogarty et al. | Jun 2004 | A1 |
20040148017 | Stobie | Jul 2004 | A1 |
20040167573 | Williamson et al. | Aug 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040206363 | McCarthy et al. | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210305 | Shu et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215235 | Jackson et al. | Oct 2004 | A1 |
20040225355 | Stevens | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040237321 | Rudko et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20040260390 | Sarac et al. | Dec 2004 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050043760 | Fogarty et al. | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050060029 | Le et al. | Mar 2005 | A1 |
20050065594 | DiMatteo et al. | Mar 2005 | A1 |
20050065614 | Stinson | Mar 2005 | A1 |
20050075584 | Cali | Apr 2005 | A1 |
20050075713 | Biancucci et al. | Apr 2005 | A1 |
20050075717 | Nguyen et al. | Apr 2005 | A1 |
20050075718 | Nguyen et al. | Apr 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050075720 | Nguyen et al. | Apr 2005 | A1 |
20050075724 | Svanidze et al. | Apr 2005 | A1 |
20050080454 | Drews et al. | Apr 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug et al. | Jun 2005 | A1 |
20050137694 | Haug et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137702 | Haug et al. | Jun 2005 | A1 |
20050159811 | Lane | Jul 2005 | A1 |
20050165477 | Anduiza et al. | Jul 2005 | A1 |
20050165479 | Drews et al. | Jul 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050192665 | Spenser et al. | Sep 2005 | A1 |
20050203616 | Cribier | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050222532 | Bertolero et al. | Oct 2005 | A1 |
20050222674 | Paine | Oct 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240259 | Sisken et al. | Oct 2005 | A1 |
20050251252 | Stobie | Nov 2005 | A1 |
20050261765 | Liddicoat | Nov 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20060004398 | Binder et al. | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058871 | Zakay et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060085060 | Campbell | Apr 2006 | A1 |
20060095125 | Chinn et al. | May 2006 | A1 |
20060122634 | Ino et al. | Jun 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060136054 | Berg et al. | Jun 2006 | A1 |
20060144441 | Acosta | Jul 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060154230 | Cunanan et al. | Jul 2006 | A1 |
20060155321 | Bressler et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060167543 | Bailey et al. | Jul 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060195184 | Lane et al. | Aug 2006 | A1 |
20060195185 | Lane et al. | Aug 2006 | A1 |
20060195186 | Drews et al. | Aug 2006 | A1 |
20060207031 | Cunanan et al. | Sep 2006 | A1 |
20060229708 | Powell et al. | Oct 2006 | A1 |
20060235508 | Lane et al. | Oct 2006 | A1 |
20060241743 | Bergin et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060246888 | Bender et al. | Nov 2006 | A1 |
20060253191 | Salahieh et al. | Nov 2006 | A1 |
20060259134 | Schwammenthal et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060271000 | Ranalletta et al. | Nov 2006 | A1 |
20060271172 | Tehrani | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20060287718 | Bicer | Dec 2006 | A1 |
20060287719 | Rowe et al. | Dec 2006 | A1 |
20060293745 | Carpentier et al. | Dec 2006 | A1 |
20070005129 | Damm et al. | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070016285 | Lane et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070078509 | Lotfy | Apr 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070100440 | Figulla et al. | May 2007 | A1 |
20070129794 | Realyvasquez | Jun 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070142907 | Moaddeb et al. | Jun 2007 | A1 |
20070150053 | Gurskis et al. | Jun 2007 | A1 |
20070156233 | Kapadia et al. | Jul 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070162107 | Haug et al. | Jul 2007 | A1 |
20070162111 | Fukamachi et al. | Jul 2007 | A1 |
20070179604 | Lane | Aug 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070198097 | Zegdi | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070203576 | Lee et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070225801 | Drews et al. | Sep 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070239266 | Birdsall | Oct 2007 | A1 |
20070239269 | Dolan et al. | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20070244558 | Machiraju | Oct 2007 | A1 |
20070255398 | Yang et al. | Nov 2007 | A1 |
20070260305 | Drews et al. | Nov 2007 | A1 |
20070265701 | Gurskis et al. | Nov 2007 | A1 |
20070270944 | Bergheim et al. | Nov 2007 | A1 |
20070282436 | Pinchuk | Dec 2007 | A1 |
20070288089 | Gurskis et al. | Dec 2007 | A1 |
20070299513 | Ryan et al. | Dec 2007 | A1 |
20080009746 | Forster et al. | Jan 2008 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080033543 | Gurskis et al. | Feb 2008 | A1 |
20080033544 | Lemmon | Feb 2008 | A1 |
20080065198 | Quintessenza | Mar 2008 | A1 |
20080119875 | Ino et al. | May 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080208331 | McCarthy et al. | Aug 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080319543 | Lane | Dec 2008 | A1 |
20090036903 | Ino et al. | Feb 2009 | A1 |
20090069890 | Suri et al. | Mar 2009 | A1 |
20090093877 | Keidar et al. | Apr 2009 | A1 |
20090132036 | Navia | May 2009 | A1 |
20090182419 | Bolling | Jul 2009 | A1 |
20090192599 | Lane et al. | Jul 2009 | A1 |
20090192600 | Ryan | Jul 2009 | A1 |
20090192602 | Kuehn | Jul 2009 | A1 |
20090192603 | Ryan | Jul 2009 | A1 |
20090192604 | Gloss | Jul 2009 | A1 |
20090192605 | Gloss et al. | Jul 2009 | A1 |
20090192606 | Gloss et al. | Jul 2009 | A1 |
20090234291 | Saunders et al. | Sep 2009 | A1 |
20100152844 | Couetil | Jun 2010 | A1 |
20100161036 | Pintor et al. | Jun 2010 | A1 |
20100241068 | Chen | Sep 2010 | A1 |
20100249661 | Righini et al. | Sep 2010 | A1 |
20100249894 | Oba et al. | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100331972 | Pintor et al. | Dec 2010 | A1 |
20110022165 | Oba et al. | Jan 2011 | A1 |
20110040372 | Hansen et al. | Feb 2011 | A1 |
20110147251 | Hodshon et al. | Jun 2011 | A1 |
20110152741 | Banchieri et al. | Jun 2011 | A1 |
20120016408 | Barbut et al. | Jan 2012 | A1 |
20120065729 | Pintor et al. | Mar 2012 | A1 |
20120071968 | Li et al. | Mar 2012 | A1 |
20120141656 | Orr et al. | Jun 2012 | A1 |
20120150288 | Hodshon et al. | Jun 2012 | A1 |
20120259273 | Moshinsky et al. | Oct 2012 | A1 |
20120302953 | Don Michael | Nov 2012 | A1 |
20130053949 | Pintor et al. | Feb 2013 | A1 |
20130116777 | Pintor et al. | May 2013 | A1 |
20130150954 | Conklin | Jun 2013 | A1 |
20140058194 | Soletti et al. | Feb 2014 | A1 |
20140079758 | Hall et al. | Mar 2014 | A1 |
Number | Date | Country |
---|---|---|
29911694 | Aug 1999 | DE |
0125393 | Nov 1984 | EP |
0143246 | Jun 1985 | EP |
0619745 | Oct 1994 | EP |
2080474 | Jul 2009 | EP |
2681775 | Apr 1993 | FR |
2083362 | Mar 1982 | GB |
2137499 | Oct 1984 | GB |
1116573 | Jul 1985 | SU |
1697790 | Dec 1991 | SU |
8102098 | Aug 1981 | WO |
8705489 | Sep 1987 | WO |
9213502 | Aug 1992 | WO |
9418909 | Sep 1994 | WO |
9516410 | Jun 1995 | WO |
9640006 | Dec 1996 | WO |
9725003 | Jul 1997 | WO |
9741801 | Nov 1997 | WO |
9742871 | Nov 1997 | WO |
9964099 | Dec 1999 | WO |
0150985 | Jul 2001 | WO |
2006093273 | Sep 2006 | WO |
2007146261 | Dec 2007 | WO |
2010090720 | Aug 2010 | WO |
2010111621 | Sep 2010 | WO |
2011097355 | Aug 2011 | WO |
2011106354 | Sep 2011 | WO |
Entry |
---|
“Freestyle Aortic Root Bioprosthesis”, Medtronic Bioprosthesis for Replacement of Malfunctioning Native or Prosthetic Aortic Valve, 4 pages, [online], [retrieved on Oct. 19, 2011]. Retrieved from the internet <URL:http://www.medtronic.com/for-healthcare-professionals/products-therapies/cardiovascula . . . . |
A. Sidiropoulos, et al., Stentless Porcine Bioprostheses for all Types of Aortic Root pathology, European Journal of Cardio-Thoracic Surgery, 1997:11:917-921. |
Int'l. Search Report for PCT/US2015/036005, Mailed Sep. 21, 2015. |
Int'l. Search Report for PCT/US2015/044003, Mailed Nov. 11, 2015. |
Krakow, “3F Therapeutics, Inc. Announces the First Clinical Implantation of the 3F Enable Aortic Heart ValveTM, a Patented, Sutureless Implantation, Replacement Heart Valve Intended to Save Valuable Surgery Time and Reduce Time Related Complications . . . ” Healthcare Sales & Marketing Network News Feed, Jan. 18, 2005, pp. 12. |
Neal D. Kon, MD, et al., Comparison of Implantation Techniques Using Freestyle Stentles Porcine Aortic Valve, The Society of Thoracic Surgeons 1995, pp. 857-862. |
Stephen Westaby, et al., Aortic Valve Replacement With the Freestyle Stentless Xenograft, The Society of Thoracic Surgeons 1995, pp. S422-S427. |
Stephen Westaby, et al., Time-Related Hemodynamic Changes After Aortic Replacement With the Freestyle Stentless Xenograft, The Society of Thoracic Surgeons 1995, pp. 857-862. |
Techniques for 3D Quantitative Echocardiography, University of Washington Cardiovascular Research & Training Center Cardiac Imaging Research Lab, pp. 1-5, Oct. 2003. |
Number | Date | Country | |
---|---|---|---|
20240091426 A1 | Mar 2024 | US |
Number | Date | Country | |
---|---|---|---|
62033987 | Aug 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16820614 | Mar 2020 | US |
Child | 18522232 | US | |
Parent | 15501801 | US | |
Child | 16820614 | US |